Morris Birnbaum, M.D., Ph.D.
Senior Vice President and Chief Scientific Officer of Internal Medicine, Pfizer Inc.
Morris Birnbaum, M.D., Ph.D. is the senior vice president and chief scientific officer of internal medicine at Pfizer Inc.
Following an associate professorship in the Department of Cell Biology at Harvard Medical School, Dr. Birnbaum moved to the University of Pennsylvania as a professor of medicine and investigator of the Howard Hughes Medical Institute, where he later became associate dean for Biomedical Cores and associate director of the Institute for Diabetes, Obesity and Metabolism. Dr. Birnbaum joined Pfizer Inc. in 2014 and assumed his current role in 2017.
Dr. Birnbaum was elected to membership in the American Society for Clinical Investigation and the Association of American Physicians, and is a fellow of the American Association for the Advancement of Science.
Dr. Birnbaum completed his undergraduate, graduate and medical training at Brown University before moving to St. Louis to carry out clinical training in internal medicine at Barnes Hospital of Washington University School of Medicine. He then performed postdoctoral studies at the University of California, San Francisco, and Sloan-Kettering Cancer Institute.